Polaris Partners
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Growth, Late Stage, Series A, Series B, Pre-IPO
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, Europe, China, India, Brazil, France, Denmark, Mexico, South Korea, Netherlands, Sweden, Belgium, Israel, Norway, Finland
Industries Focus
- Financial Services
- Technology
- Healthcare
- Energy
- Real Estate
- Telecommunications
- Media
- Retail
- Education
- Industrial
- Consumer Products
- Transportation
- Hospitality
- Consumer Services
- Biotechnology
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 1996
Polaris Partners is a prominent venture capital firm specializing in early-stage investments in technology and life sciences sectors. With a team comprising entrepreneurs, scientists, and operators, the firm is dedicated to supporting transformative companies that aim to make a significant impact on the world. Their collaborative approach ensures deep engagement and support for portfolio companies, fostering innovation and growth.
The firm's investment strategy focuses on identifying and nurturing companies across various stages, from seed to late-stage, with a particular emphasis on sectors such as technology, healthcare, biotechnology, and consumer products. Polaris Partners has a global investment reach, with a presence in the United States, Canada, Europe, Israel, China, India, Japan, South Korea, Australia, Brazil, Mexico, the United Kingdom, Germany, France, Sweden, Denmark, Norway, Finland, the Netherlands, and Belgium.
With over $5 billion in committed capital, Polaris Partners has a proven track record of creating successful companies that change the world. Their unwavering commitment, exceptional counsel, and broad experience have been integral to the continued growth and success of the companies they collaborate with, making Polaris Partners a true extension of their partners' teams.
Requirements
- Innovative healthcare or biotechnology companies
- Strong management teams
- Scalable business models
- Innovative technology solutions
- Clear market differentiation
- Potential for significant impact
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Alnylam Pharmaceuticals
- Foundation Medicine
- Aegerion Pharmaceuticals
- T2 Biosystems
- Avedro
- Aptinyx
- Aptalis Pharma
- Biogen
- CureMetrix
- Dicerna Pharmaceuticals
- Enanta Pharmaceuticals
- Fate Therapeutics
- G1 Therapeutics
- Ginkgo Bioworks
- GRAIL
- Kura Oncology
- Loxo Oncology
- Mersana Therapeutics
- NantKwest
- NantWorks
- NantCell
- NantPharma
- NantHealth
- NantBioScience
Mentioned In
-
$49.95
-
$14.95
-
$39.95
-
$24.95
-
$19.95
-
$24.95
-
$9.95
-
$99.00
-
$299.00
Claim this Investor
Are you an official representative of Polaris Partners?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim